GSK and Vir Biotechnology expand coronavirus collaboration
GlaxoSmithKline plc (GSK) and Vir Biotechnology, Inc. have entered into an agreement to expand their existing collaboration to include the research and development of...
New partnership ensures dispensing between pharmacies and care homes is seamless
MED e‐care and Cegedim have announced a new partnership to integrate Cegedim’s Pharmacy Manager with MED e‐care’s electronic Medication Administration Record (eMAR). The integration of...
Positive phase III results for Lilly’s tirzepatide in type 2 diabetes
Lilly has announced positive first data from two phase III trials, showing that tirzepatide led to significant reductions in HbA1c and body weight reductions...
MHRA launches public consultation on two contraceptive pills
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on the reclassification of two progestogen-only contraceptive pills containing desogestrel. The consultation...
LEO Pharma appoints new Vice President
LEO Pharma has appointed Sarah Kleinpeter as Vice President of UK and Ireland, succeeding the outgoing Vice President and Managing Director Geraldine Murphy, who...
Positive phase III data for Roche’s vision loss therapy
New phase III data show Roche’s faricimab is the first investigational injectable eye medicine to extend time between treatments up to four months in...
Sandoz acquires GSK’s cephalosporin antibiotics business
Sandoz has signed an agreement to acquire GSK’s cephalosporin antibiotics business, which includes the global rights to three established brands (Zinnat®, Zinacef® and Fortum®)...
Blueprint launched for NHS reform following COVID-19 pandemic
The Health and Social Care Secretary, with the support of NHS England and health and care system leaders, will today set out new proposals...
NIHR funds study to improve the lives of people with cystic fibrosis
The NIHR has awarded funding to the University of Liverpool and Alder Hey Children’s Hospital to conduct a trial to improve the lives of...
World’s first clinical trials of COVID-19 vaccine combination
In a bid to combat future mutations of COVID-19, a joint research programme will begin in February 2021 to assess the immunogenicity and safety...